Middle Eastern stock markets are currently experiencing mixed performances as investors closely monitor geopolitical developments, particularly the ongoing US-Iran talks. For those looking to explore beyond well-known companies, penny stocks—often representing smaller or newer enterprises—continue to present intriguing opportunities despite their somewhat outdated label. By focusing on stocks with solid financial foundations and potential for growth, investors can find promising options that may offer both stability and upside in today's market climate.
Top 10 Penny Stocks In The Middle East
| Name |
Share Price |
Market Cap |
Financial Health Rating |
| Al-Modawat Specialized Medical (SASE:9594) |
SAR3.92 |
SAR279.08M |
★★★★☆☆ |
| ADNOC Gas (ADX:ADNOCGAS) |
AED3.20 |
AED246.26B |
★★★★★★ |
| Thob Al Aseel (SASE:4012) |
SAR3.71 |
SAR1.48B |
★★★★★★ |
| Alpha Data PJSC (ADX:ALPHADATA) |
AED1.51 |
AED1.53B |
★★★★★☆ |
| Al Wathba National Insurance Company PJSC (ADX:AWNIC) |
AED3.04 |
AED629.28M |
★★★★★★ |
| Dubai Investments PJSC (DFM:DIC) |
AED3.81 |
AED16.16B |
★★★★★☆ |
| Al Waha Capital PJSC (ADX:WAHA) |
AED1.73 |
AED3.28B |
★★★★★☆ |
| Abu Dhabi National Hotels Company PJSC (ADX:ADNH) |
AED0.393 |
AED4.96B |
★★★★★★ |
| Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) |
AED1.04 |
AED632.58M |
★★★★★☆ |
| Tgi Infrastructures (TASE:TGI) |
₪2.60 |
₪204.1M |
★★★★★★ |
Click here to see the full list of 81 stocks from our Middle Eastern Penny Stocks screener.
Let's dive into some prime choices out of the screener.
Orçay Ortaköy Çay Sanayi ve Ticaret Anonim Sirketi
Simply Wall St Financial Health Rating:★★★★☆☆
Overview:Orçay Ortaköy Çay Sanayi ve Ticaret Anonim Sirketi is engaged in the production, marketing, and sale of various tea and related products primarily in Turkey, with a market cap of TRY268.80 million.
Operations:The company's revenue is primarily derived from its food processing segment, which generated TRY661.59 million.
Market Cap:TRY268.8M
Orçay Ortaköy Çay Sanayi ve Ticaret Anonim Sirketi, despite its unprofitability and a negative return on equity of -22.66%, maintains a positive outlook with sufficient cash runway for over three years due to growing free cash flow. The company's revenue increased to TRY661.59 million in 2025, although it reported a net loss of TRY161.4 million. While short-term liabilities exceed assets, long-term liabilities are covered by short-term assets of TRY789.1 million. Additionally, the debt-to-equity ratio has improved significantly over the past five years from 138.7% to 73.5%.
Allmed Solutions
Simply Wall St Financial Health Rating:★★★★★★
Overview:Allmed Solutions Ltd develops, manufactures, and markets minimally invasive medical products in Israel and internationally with a market cap of ₪35.91 million.
Operations:Revenue Segments: No specific revenue segments have been reported for Allmed Solutions Ltd.
Market Cap:₪35.91M
Allmed Solutions Ltd, with a market cap of ₪35.91 million, remains pre-revenue and unprofitable, reporting a net loss of ILS 14.12 million for 2025. Despite this, the company is debt-free and its short-term assets of ₪30.4 million comfortably cover both short-term (₪2.9M) and long-term liabilities (₪527K). Recent private placements raised ILS 1.57 million to bolster cash reserves further. The board's experience averages 6.5 years, indicating seasoned oversight; however, the stock's high volatility persists alongside declining earnings over five years at an annual rate of nearly 30%.
-
Explore historical data to track Allmed Solutions' performance over time in our past results report.
Pomvom
Simply Wall St Financial Health Rating:★★★★★☆
Overview:Pomvom Ltd develops systematic solutions for image recognition documentation in Israel and has a market cap of ₪24.88 million.
Operations:There are no reported revenue segments for this company.
Market Cap:₪24.88M
Pomvom Ltd, with a market cap of ₪24.88 million, reported sales of ILS 220.9 million for 2025 but remains unprofitable with a net loss of ILS 8.67 million, an improvement from the previous year. The company has more cash than debt and sufficient assets to cover both short and long-term liabilities, suggesting financial stability despite its high share price volatility and negative return on equity (-58.73%). The board and management team are experienced, averaging tenures of 4.5 and 7 years respectively, providing seasoned leadership as the company navigates its challenging financial landscape.
-
Dive into the specifics of Pomvom here with our thorough balance sheet health report.
-
Review our historical performance report to gain insights into Pomvom's track record.
Taking Advantage
-
Discover the full array of 81 Middle Eastern Penny Stocks right here.
-
Searching for a Fresh Perspective? The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 21 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include IBSE:ORCAY TASE:ALMD and TASE:PMVM.
This article was originally published by Simply Wall St .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
